Clinical Trials Directory

Trials / Completed

CompletedNCT00888368

Accuracy of the Transpatellar Tendon Approach to Knee Arthrocentesis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Denver Health and Hospital Authority · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is: * To determine the accuracy of intraarticular placement with the transpatellar tendon approach as compared to the suprapatellar approach. Patients undergoing knee arthroscopy will be consented for study of the injection of the fluid into the joint prior to portal placement or commencement of knee replacement. Patients will be randomized to receive injections via the transpatellar tendon or superolateral approach. Using injectable contrast and fluoroscopy, the placement of injections into the knee will be evaluated for accuracy. Injection attempts with contrast fluid that uniformly coats the articular surface on sagittal and coronal radiographs will be counted as successful. A concentration of contrast fluid in extraarticular fat will be counted as a failure. Hypothesis: The rate of accuracy of intraarticular placement of the needle tip via the transpatellar tendon approach to knee aspiration is greater than that of the superolateral approach. * To determine the distribution of contrast material with the transpatellar tendon and superolateral apporaches. Using a previously described evaluation technique of dividing the knee into seven compartments, sagittal and coronal fluoroscopy images will be evaluated to determine the distribution of contrast fluid. Hypothesis: Contrast injected into the knee via the trasnpatellar tendon approach will penetrate as many compartments of the knee as contrast injected via the superolateral approach.

Conditions

Interventions

TypeNameDescription
PROCEDURETranspatellar ApproachThe transpateller approach for the injection of the dye will be used.
PROCEDURESuprapatellarThe suprapatellar approach will be used for the injection of the dye.

Timeline

Start date
2008-01-01
Primary completion
2009-08-01
Completion
2009-08-01
First posted
2009-04-27
Last updated
2012-07-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00888368. Inclusion in this directory is not an endorsement.